<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="" xml:lang="">
<head>

  <meta charset="utf-8" />
  <meta http-equiv="X-UA-Compatible" content="IE=edge" />
  <title>2 Report | Annual review: year2</title>
  <meta name="description" content="2 Report | Annual review: year2" />
  <meta name="generator" content="bookdown 0.16 and GitBook 2.6.7" />

  <meta property="og:title" content="2 Report | Annual review: year2" />
  <meta property="og:type" content="book" />
  
  
  
  

  <meta name="twitter:card" content="summary" />
  <meta name="twitter:title" content="2 Report | Annual review: year2" />
  
  
  




  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <meta name="apple-mobile-web-app-capable" content="yes" />
  <meta name="apple-mobile-web-app-status-bar-style" content="black" />
  
  
<link rel="prev" href="star-report.html"/>

<script src="libs/jquery-2.2.3/jquery.min.js"></script>
<link href="libs/gitbook-2.6.7/css/style.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-table.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-bookdown.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-highlight.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-search.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-fontsettings.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-clipboard.css" rel="stylesheet" />












<link rel="stylesheet" href="custom.css" type="text/css" />
</head>

<body>



  <div class="book without-animation with-summary font-size-2 font-family-1" data-basepath=".">

    <div class="book-summary">
      <nav role="navigation">

<ul class="summary">
<li class="chapter" data-level="1" data-path="star-report.html"><a href="star-report.html"><i class="fa fa-check"></i><b>1</b> STaR report</a>
<ul>
<li class="chapter" data-level="1.1" data-path="star-report.html"><a href="star-report.html#introduction"><i class="fa fa-check"></i><b>1.1</b> Introduction</a>
<ul>
<li class="chapter" data-level="1.1.1" data-path="star-report.html"><a href="star-report.html#title"><i class="fa fa-check"></i><b>1.1.1</b> Title</a></li>
<li class="chapter" data-level="1.1.2" data-path="star-report.html"><a href="star-report.html#maximum-submission-date"><i class="fa fa-check"></i><b>1.1.2</b> Maximum submission date</a></li>
</ul></li>
<li class="chapter" data-level="1.2" data-path="star-report.html"><a href="star-report.html#looking-back"><i class="fa fa-check"></i><b>1.2</b> Looking back</a>
<ul>
<li class="chapter" data-level="1.2.1" data-path="star-report.html"><a href="star-report.html#research-progress"><i class="fa fa-check"></i><b>1.2.1</b> Research progress</a></li>
</ul></li>
<li class="chapter" data-level="1.3" data-path="star-report.html"><a href="star-report.html#planning-ahead"><i class="fa fa-check"></i><b>1.3</b> Planning ahead</a>
<ul>
<li class="chapter" data-level="1.3.1" data-path="star-report.html"><a href="star-report.html#research-objectives"><i class="fa fa-check"></i><b>1.3.1</b> Research objectives</a></li>
</ul></li>
</ul></li>
<li class="chapter" data-level="2" data-path="report.html"><a href="report.html"><i class="fa fa-check"></i><b>2</b> Report</a>
<ul>
<li class="chapter" data-level="2.1" data-path="report.html"><a href="report.html#title-page"><i class="fa fa-check"></i><b>2.1</b> Title page</a></li>
<li class="chapter" data-level="2.2" data-path="report.html"><a href="report.html#main-report"><i class="fa fa-check"></i><b>2.2</b> Main report</a>
<ul>
<li class="chapter" data-level="2.2.1" data-path="report.html"><a href="report.html#overview-of-phd"><i class="fa fa-check"></i><b>2.2.1</b> Overview of PhD</a></li>
<li class="chapter" data-level="2.2.2" data-path="report.html"><a href="report.html#other-work"><i class="fa fa-check"></i><b>2.2.2</b> Other work</a></li>
</ul></li>
<li class="chapter" data-level="2.3" data-path="report.html"><a href="report.html#turnitin"><i class="fa fa-check"></i><b>2.3</b> Turnitin</a></li>
<li class="chapter" data-level="2.4" data-path="report.html"><a href="report.html#presentation"><i class="fa fa-check"></i><b>2.4</b> Presentation</a></li>
</ul></li>
</ul>

      </nav>
    </div>

    <div class="book-body">
      <div class="body-inner">
        <div class="book-header" role="navigation">
          <h1>
            <i class="fa fa-circle-o-notch fa-spin"></i><a href="./">Annual review: year2</a>
          </h1>
        </div>

        <div class="page-wrapper" tabindex="-1" role="main">
          <div class="page-inner">

            <section class="normal" id="section-">
<div id="report" class="section level1">
<h1 number="2"><span class="header-section-number">2</span> Report</h1>
<div id="title-page" class="section level2">
<h2 number="2.1"><span class="header-section-number">2.1</span> Title page</h2>
<p><strong>Current date</strong>: 26/12/2019</p>
<p><strong>Author</strong>: Matthew Lee</p>
<p><strong>Supervisors</strong>:</p>
<ul>
<li>Nic Timpson</li>
<li>Kaitlin Wade</li>
<li>Laura Corbin</li>
</ul>
<p><strong>Title</strong>: What lies behind the causal impact of body mass index (BMI) level and change on human health? Added value from complementary study design and deep metabolomic phenotyping*</p>
<p><strong>Date of commencement</strong>: 01/10/2017</p>
<p><strong>Expected submission</strong>: 01/10/2021</p>
<div style="page-break-after: always;"></div>
</div>
<div id="main-report" class="section level2">
<h2 number="2.2"><span class="header-section-number">2.2</span> Main report</h2>
<div id="overview-of-phd" class="section level3">
<h3 number="2.2.1"><span class="header-section-number">2.2.1</span> Overview of PhD</h3>
<p>I am on a 3.5-year GW4 BioMed MRC DTP PhD. I am in my third year and expect to finish April 2021.</p>
<div id="rationale" class="section level4">
<h4 number="2.2.1.1"><span class="header-section-number">2.2.1.1</span> Rationale</h4>
<p>The number of individuals suffering from overweight and obesity is at an all time high. Globally, 39% and 13% of adults (18+) are estimated to be overweight or obese<span class="citation"><sup><a href="#ref-WorldHealthOrganisation2018" role="doc-biblioref">1</a></sup></span>(Figure <a href="report.html#fig:overweight-graph">2</a> and <a href="report.html#fig:obesity-graph">3</a>) and this number is expected to continue to rise<span class="citation"><sup><a href="#ref-Ng2014" role="doc-biblioref">2</a>–<a href="#ref-Abarca-Gomez2017" role="doc-biblioref">4</a></sup></span>. It is estimated that obesity is repsonsible for 8% of global deaths<span class="citation"><sup><a href="#ref-Stanaway2018" role="doc-biblioref">5</a></sup></span>(Figure <a href="report.html#fig:mortality-graph">4</a>). With the number of overweight and obese individuals increasing<span class="citation"><sup><a href="#ref-Ng2014" role="doc-biblioref">2</a>–<a href="#ref-Abarca-Gomez2017" role="doc-biblioref">4</a></sup></span> it is likely the number of premature deaths will rise too. <br></p>
<div class="figure"><span id="fig:overweight-graph"></span>
<img src="../../index/data/chapter1/share-of-adults-who-are-overweight.png" alt="Proportion of overweight individuals" width="100%" />
<p class="caption">
Figure 2: Proportion of overweight individuals
</p>
</div>
<p>
<em>Figure <a href="report.html#fig:overweight-graph">2</a>, reproduced from Ritchie and Roser (2019)<span class="citation"><sup><a href="#ref-Ritchie2019" role="doc-biblioref">6</a></sup></span>, shows the share of adults (18+) that are overweight globally and in 5 selected geographic regions (Americas, Europe, Eastern Mediteranean, Africa and Sout East Asia) from 1975 to 2016.</em> <br></p>
<div class="figure"><span id="fig:obesity-graph"></span>
<img src="../../index/data/chapter1/share-of-adults-defined-as-obese.png" alt="Proportion of obese individuals" width="100%" />
<p class="caption">
Figure 3: Proportion of obese individuals
</p>
</div>
<p>
<em>Figure <a href="report.html#fig:obesity-graph">3</a>, reproduced from Ritchie and Roser (2019)<span class="citation"><sup><a href="#ref-Ritchie2019" role="doc-biblioref">6</a></sup></span>, shows the share of adults (18+) that are obese globally and in 5 selected geographic regions (Americas, Europe, Eastern Mediteranean, Africa and Sout East Asia) from 1975 to 2016.</em> <br></p>
<div class="figure"><span id="fig:mortality-graph"></span>
<img src="../../index/data/chapter1/number-of-deaths-by-risk-factor.png" alt="Number of deaths by risk factor" width="100%" />
<p class="caption">
Figure 4: Number of deaths by risk factor
</p>
</div>
<p>
<em>Figure <a href="report.html#fig:mortality-graph">4</a>, reproduced from Ritchie and Roser (2019)<span class="citation"><sup><a href="#ref-Ritchie2019" role="doc-biblioref">6</a></sup></span>, shows the number of deaths for 26 risk factors globally in 2017 for all age groups. Obesity is the 5th leading cause of death with 3.41 million deaths in 2017.</em> <br></p>
<p>Conventionally, overweight and obesity is measured using body mass index (BMI), with overweight and obesity classified as a BMI of 25–29.9 kg/m<sup>2</sup> and &gt; 30 kg/m<sup>2</sup> respectively. A normal weight classification is a BMI of 18.5–24.9 kg/m<sup>2</sup>, with an underweight class below this. In the crudest sense, BMI is a measure of weight given an adjustment of height. BMI is associated with numerous diseases and provides an accurate measure of risk at a population level for many. However, BMI does not have the resolution to accurately measure an individual’s body composition<span class="citation"><sup><a href="#ref-Pischon2008" role="doc-biblioref">7</a>–<a href="#ref-Pasco2012" role="doc-biblioref">10</a></sup></span> i.e. the amount and location of adipose tissue within the body - studies have pointed to a more important role for fat deposition in disease development<span class="citation"><sup><a href="#ref-Sahakyan2015" role="doc-biblioref">11</a>,<a href="#ref-Hamer2017" role="doc-biblioref">12</a></sup></span>. As such, complimnetary assesment of increased adiposity using a combination of body composition measures (i.e. BMI, waist hip ratio, body fat %) may provide additional information into associations with disease<span class="citation"><sup><a href="#ref-WorldHealthOrganisation2008" role="doc-biblioref">13</a>,<a href="#ref-Collaboration2009" role="doc-biblioref">14</a></sup></span>. <br></p>
<p>Aipose tissues are prolific signallers to surrounding and systemic tissues<span class="citation"><sup><a href="#ref-Lehr2012" role="doc-biblioref">15</a>,<a href="#ref-Fasshauer2015" role="doc-biblioref">16</a></sup></span> leading to large downstream affects with potentially harmful consequences<span class="citation"><sup><a href="#ref-Fasshauer2015" role="doc-biblioref">16</a>–<a href="#ref-Luo2016" role="doc-biblioref">19</a></sup></span>. Changes to adipose tissue abundance is refelcted in adipocyte signalling. This change is concurrent with shifts in metabolic profiles, where alterations to the level of one metabolite does not occur in isolation. Metabolites sit at the interface between genetic and non-genetic factors, provide a useful read-out of physiological function, and have been genetically well characterised<span class="citation"><sup><a href="#ref-Shin2014" role="doc-biblioref">20</a>,<a href="#ref-Kettunen2016" role="doc-biblioref">21</a></sup></span>.</p>
</div>
<div id="aims" class="section level4">
<h4 number="2.2.1.2"><span class="header-section-number">2.2.1.2</span> Aims</h4>
<p>The biological pathway from increased adiposity to diseases development is unclear. Adipose tissue is a prolific signalling organ resulting in systemic changes across the body. Metabolic changes may be a result of increased adiposity and subsequent signalling and evidence has highlited the role of metabolites in disease. The aim of this thesis is to: <br></p>
<ul>
<li><strong>Identify metabolites that sit on the causal pathway from increased adiposity to disease</strong></li>
</ul>
</div>
<div id="objectives" class="section level4">
<h4 number="2.2.1.3"><span class="header-section-number">2.2.1.3</span> Objectives</h4>
<p>In order to achieve this aim and better understand the biological mechanisms underlying development of disease this thesis will:</p>
<ol style="list-style-type: decimal">
<li>Identify all traits causally associated with increased adiposity
<ul>
<li>we will perform a systematic review of allMenderlin randomization studies investigating measures of increased adiposity with any outcome</li>
<li>we will use the findings from this review to guide subsequent work <br></li>
</ul></li>
</ol>
<ol start="2" style="list-style-type: decimal">
<li>Identify and describe appropriate instrumentation of increased adiposity <br></li>
</ol>
<ol start="3" style="list-style-type: decimal">
<li>Identify metabolites associated with increased adiposity
<ul>
<li>We will use observational and Mendelian randomization analyses to identify metabolites associated with multiple measures of increased adiposity <br></li>
</ul></li>
</ol>
<ol start="4" style="list-style-type: decimal">
<li>Design and implement methods to cluster metabolites
<ul>
<li>Metabolites are complicated and highly correlated; we will develop methods to cluster metabolites and propose rules for instrumenting metabolites and clusters for Mendelian randomization analyses <br></li>
</ul></li>
</ol>
<ol start="5" style="list-style-type: decimal">
<li>Identify diseases associated with metabolites
<ul>
<li>We will use observational and Mendelian randomization analyses to identify metabolites associated with diseases</li>
<li>We will be guided by the systematci review and metabolites we identify as associated with increased adiposity <br></li>
</ul></li>
</ol>
</div>
<div id="layout" class="section level4">
<h4 number="2.2.1.4"><span class="header-section-number">2.2.1.4</span> Layout</h4>
<div class="figure"><span id="fig:chapter-overview"></span>
<img src="../../index/data/thesis_outline-Page-2.svg" alt="Overview of PhD chapters" width="100%" />
<p class="caption">
Figure 5: Overview of PhD chapters
</p>
</div>
<p><em>Figure <a href="report.html#fig:chapter-overview">5</a> shows an overview of proposed chapters for the thesis, including progress to date and expected outcomes, in order to achieve the described aim and objectives. To enlarge: right click -&gt; open image in new tab</em></p>
</div>
</div>
<div id="other-work" class="section level3">
<h3 number="2.2.2"><span class="header-section-number">2.2.2</span> Other work</h3>
<div id="placement" class="section level4">
<h4 number="2.2.2.1"><span class="header-section-number">2.2.2.1</span> Placement</h4>
<p>Funds have been requested (to extend the PhD by three months) to enable Matthew to work with Professor Ruth Loos at the Ichan School of Medicine at Mount Sinai, New York and undergo training in computational and data analytics to characterise the genetics of body composition, which will enable him to expand his current analysis investigating adiposity -&gt; metabolites -&gt; diseases to more accurate measures of body composition.</p>
<p>Matthew has investigated the effects of BMI and WHR but the lack of strong genetic characterisation for BF limits the understanding we can gain from these analyses. Matthew has also been using combinations of measures (profiles) to investigate the underlying biological mechanisms driving associations and is developing ways to investigate metabolites as profiles of risk. Combining the skills, expertise and data of our and Professor Loos’ groups will enable Matthew to expand his work into BF, and thus gain a better understanding of the biological mechanisms driving associations between increased adiposity and disease.</p>
<p>Matthew will work with Professor Loos, a world leader in human genetics and body composition, to explore BF genetics and increased adiposity profiles. Professor Loos is a member of the steering committee for the global BMI genome-wide association study (GWAS) consortia and set-up the global body composition GWAS consortia. The Loos Lab are an interdisciplinary team aiming to identify and characterize genes to better understand biological pathways. The team includes JJ Wang, Postdoctoral Fellow, has expertise in integrating genomics and metabolomics data; Arden Moscati, a Computational Geneticist, has expertise in etiological overlap between traits and diseases; Daiane Hemerich, Postdoctoral Fellow, has expertise in fine-mapping and functional annotation. Much of the labs work is conducted in BioMe, a biobank of ~50,000 ancestrally diverse (European (32%), African (24%), Hispanic/Latino (35%) and other/mixed ancestries (9%)) individuals.</p>
<p>Matthew will contribute to characterizing the genetics of BF using whole genome and exome sequence data. This will involve the use of fine-mapping, co-localisation and integrated approaches to investigate the genetics of multiple measures of body composition. This placement, discussed and agreed with Professor Loos, is a natural and valuable progression of Matthew’s work to develop our understanding of the mechanisms driving disease risk. With UK Biobank due to release metabolite data at a similar time, the placement will provide the appropriate data and skills to (i) identify genetic variants for MR investigations of metabolites and diseases and (ii) to integrate these genetic variants with the metabolomics work already completed and to be performed in UK Biobank.</p>
</div>
<div id="gwas-of-glycosuria" class="section level4">
<h4 number="2.2.2.2"><span class="header-section-number">2.2.2.2</span> GWAS of glycosuria</h4>
<p>We conducted a genome-wide association study (GWAS) of glycosuria (sugar in urine) in pregnant mothers from the Avon Longitudinal Study of Parents and Children (ALSPAC). Due to a lack of available external data sources replication was not possible, instead we performed a GWAS in the Northern Finland Birth Cohort 1986 (NFBC1986) where we used mothers phenotype and the mothers’ offsprings genotype. To estimate the maternal effects from offspring genotypes we doubled the effect estimates and standard errors of the GWAS results<span class="citation"><sup><a href="#ref-Wacholder1998" role="doc-biblioref">22</a>–<a href="#ref-Joshi2017" role="doc-biblioref">24</a></sup></span>. The <a href="https://github.com/mattlee821/001_glycosuria_GWAS">GitHub repository</a> provides all scripts and data.</p>
</div>
<div id="abstract" class="section level4">
<h4 number="2.2.2.3"><span class="header-section-number">2.2.2.3</span> Abstract</h4>
<p>Glycosuria is a condition where glucose is detected in urine at higher concentrations than normal. Glycosuria at some point during pregnancy has an estimated prevalence of 50% and is associated with adverse outcomes in both mothers and offspring. Little is currently known about the genetic contribution to this trait or the extent to which it overlaps with other seemingly related traits, e.g. diabetes. We performed a genome-wide association study (GWAS) for self-reported glycosuria in pregnant mothers from the Avon Longitudinal Study of Parents and Children (ALSPAC; cases/controls=1,249/5,140). We identified two loci, one of which (lead SNP=rs13337037; chromosome 16; odds ratio (OR) of glycosuria per effect allele: 1.42; 95%CI: 1.30,1.56; P=1.97x10-13) was then validated using an obstetric-measure of glycosuria measured in the same cohort (227/6,639). We performed a secondary GWAS in the 1986 Northern Finland Birth Cohort (NFBC1986; 747/2,991) using midwife-reported glycosuria and offspring genotype as a proxy for maternal genotype. The equivalent effect estimate for rs13337037 in this cohort was OR 1.57 (95% CI: 1.30,1.83; P=9.8x10-4). In follow-up analyses, we saw little evidence of shared genetic underpinnings with the exception of urinary albumin-to-creatinine ratio (Rg=0.64; SE=0.22; P=0.0042), a biomarker of kidney disease. In conclusion, we identified a genetic association with self-reported glycosuria during pregnancy, with the lead SNP located 15kB upstream of SLC5A2, a target of antidiabetic drugs. The lack of strong genetic correlation with seemingly related traits such as type 2 diabetes suggests different genetic risk factors exist for glycosuria during pregnancy.</p>
<div class="figure"><span id="fig:unnamed-chunk-3"></span>
<img src="glycosuria_manhattan_plot.png" alt="Manhattan plot of a GWAS of glycosuria in ALSPAC mothers" width="100%" />
<p class="caption">
Figure 6: Manhattan plot of a GWAS of glycosuria in ALSPAC mothers
</p>
</div>
</div>
<div id="public-engagement" class="section level4">
<h4 number="2.2.2.4"><span class="header-section-number">2.2.2.4</span> Public Engagement</h4>
</div>
</div>
</div>
<div id="turnitin" class="section level2">
<h2 number="2.3"><span class="header-section-number">2.3</span> Turnitin</h2>
<p><em>A copy of the Turnitin report of your end of year report – after completing your end of year report you should submit it to Turnitin via Blackboard as per the instructions provided during your induction. If you are unsure about how to do this please contact your Postgraduate Tutor and/or your School’s Graduate Directors. After submitting your report Turnitin will generate a similarity report which can be downloaded. Please review this, discuss any concerns with your supervisor and submit a copy with your end of year progress report.</em></p>
</div>
<div id="presentation" class="section level2">
<h2 number="2.4"><span class="header-section-number">2.4</span> Presentation</h2>
<p><em>During the independent review meeting you will be asked to give a formal presentation lasting not more than 15minutes at the start of the meeting. This should cover progress to date and plans for the remainder of your PhD.</em></p>
<p><a href="">Link to presentation</a></p>
<div id="refs" class="references">
<div>
<p>1. World Health Organisation. <em>Factsheet: Obesity and overweight</em>. (2018).</p>
</div>
<div>
<p>2. Ng, M. <em>et al.</em> Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. <em>Lancet (London, England)</em> <strong>384</strong>, 766–781 (2014).</p>
</div>
<div>
<p>3. (NCD-RisC), N. R. F. C. Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 192 million participants. <em>The Lancet</em> <strong>387</strong>, 1377–1396 (2016).</p>
</div>
<div>
<p>4. Abarca-Gómez, L. <em>et al.</em> Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128&amp;#xb7;9 million children, adolescents, and adults. <em>The Lancet</em> <strong>390</strong>, 2627–2642 (2017).</p>
</div>
<div>
<p>5. Stanaway, J. D. <em>et al.</em> Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Stu. <em>The Lancet</em> <strong>392</strong>, 1923–1994 (2018).</p>
</div>
<div>
<p>6. Ritchie, H. &amp; Roser, M. Obesity. Published online at OurWorldInData.org. Retrieved from: ’https://ourworldindata.org/obesity’ [Online Resource] 05/12/2019. (2019).</p>
</div>
<div>
<p>7. Pischon, T. <em>et al.</em> General and Abdominal Adiposity and Risk of Death in Europe. <em>New England Journal of Medicine</em> <strong>359</strong>, 2105–2120 (2008).</p>
</div>
<div>
<p>8. Romero-Corral, A. <em>et al.</em> Accuracy of body mass index in diagnosing obesity in the adult general population. <em>International Journal of Obesity</em> <strong>32</strong>, 959–966 (2008).</p>
</div>
<div>
<p>9. Okorodudu, D. O. <em>et al.</em> Diagnostic performance of body mass index to identify obesity as defined by body adiposity: a systematic review and meta-analysis. <em>International Journal of Obesity</em> <strong>34</strong>, 791–799 (2010).</p>
</div>
<div>
<p>10. Pasco, J. A., Nicholson, G. C., Brennan, S. L. &amp; Kotowicz, M. A. Prevalence of obesity and the relationship between the body mass index and body fat: Cross-sectional, population-based data. <em>PLoS ONE</em> <strong>7</strong>, (2012).</p>
</div>
<div>
<p>11. Sahakyan, K. R. <em>et al.</em> Normal-Weight Central Obesity: Implications for Total and Cardiovascular Mortality. <em>Annals of internal medicine</em> <strong>163</strong>, 827–835 (2015).</p>
</div>
<div>
<p>12. Hamer, M., O’Donovan, G., Stensel, D. &amp; Stamatakis, E. Normal-Weight Central Obesity and Risk for Mortality. <em>Annals of Internal Medicine</em> <strong>166</strong>, 917–918 (2017).</p>
</div>
<div>
<p>13. World Health Organisation. <em>Waist Circumference and Waist-Hip Ratio: Report of a WHO Expert Consultation</em>. (WHO, 2008).</p>
</div>
<div>
<p>14. Prospective Studies Collaboration <em>et al.</em> Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. <em>Lancet (London, England)</em> <strong>373</strong>, 1083–1096 (2009).</p>
</div>
<div>
<p>15. Lehr, S., Hartwig, S. &amp; Sell, H. Adipokines: A treasure trove for the discovery of biomarkers for metabolic disorders. <em>PROTEOMICS – Clinical Applications</em> <strong>6</strong>, 91–101 (2012).</p>
</div>
<div>
<p>16. Fasshauer, M. &amp; Blüher, M. Adipokines in health and disease. <em>Trends in Pharmacological Sciences</em> <strong>36</strong>, 461–470 (2015).</p>
</div>
<div>
<p>17. Blüher, M. Adipose tissue dysfunction contributes to obesity related metabolic diseases. <em>Best Practice &amp; Research Clinical Endocrinology &amp; Metabolism</em> <strong>27</strong>, 163–177 (2013).</p>
</div>
<div>
<p>18. Blüher, M. &amp; Mantzoros, C. S. From leptin to other adipokines in health and disease: Facts and expectations at the beginning of the 21st century. <em>Metabolism</em> <strong>64</strong>, 131–145 (2015).</p>
</div>
<div>
<p>19. Luo, L. &amp; Liu, M. Adipose tissue in control of metabolism. <em>Journal of Endocrinology</em> <strong>231</strong>, R77–R99 (2016).</p>
</div>
<div>
<p>20. Shin, S.-Y. <em>et al.</em> An atlas of genetic influences on human blood metabolites. <em>Nature Genetics</em> <strong>46</strong>, 543 (2014).</p>
</div>
<div>
<p>21. Kettunen, J. <em>et al.</em> Genome-wide study for circulating metabolites identifies 62 loci and reveals novel systemic effects of LPA. <em>Nature Communications</em> <strong>7</strong>, 11122 (2016).</p>
</div>
<div>
<p>22. Wacholder, S. <em>et al.</em> The kin-cohort study for estimating penetrance. <em>American journal of epidemiology</em> <strong>148</strong>, 623–630 (1998).</p>
</div>
<div>
<p>23. Joshi, P. K. <em>et al.</em> Variants near CHRNA3/5 and APOE have age- and sex-related effects on human lifespan. <em>Nature communications</em> <strong>7</strong>, 11174 (2016).</p>
</div>
<div>
<p>24. Joshi, P. K. <em>et al.</em> Genome-wide meta-analysis associates HLA-DQA1/DRB1 and LPA and lifestyle factors with human longevity. <em>Nature communications</em> <strong>8</strong>, 910 (2017).</p>
</div>
</div>
</div>
</div>
<h3>References</h3>
<div id="refs" class="references">
<div id="ref-WorldHealthOrganisation2018">
<p>1. World Health Organisation. <em>Factsheet: Obesity and overweight</em>. (2018).</p>
</div>
<div id="ref-Ng2014">
<p>2. Ng, M. <em>et al.</em> Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. <em>Lancet (London, England)</em> <strong>384</strong>, 766–781 (2014).</p>
</div>
<div id="ref-Abarca-Gomez2017">
<p>4. Abarca-Gómez, L. <em>et al.</em> Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128&amp;#xb7;9 million children, adolescents, and adults. <em>The Lancet</em> <strong>390</strong>, 2627–2642 (2017).</p>
</div>
<div id="ref-Stanaway2018">
<p>5. Stanaway, J. D. <em>et al.</em> Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Stu. <em>The Lancet</em> <strong>392</strong>, 1923–1994 (2018).</p>
</div>
<div id="ref-Ritchie2019">
<p>6. Ritchie, H. &amp; Roser, M. Obesity. Published online at OurWorldInData.org. Retrieved from: ’https://ourworldindata.org/obesity’ [Online Resource] 05/12/2019. (2019).</p>
</div>
<div id="ref-Pischon2008">
<p>7. Pischon, T. <em>et al.</em> General and Abdominal Adiposity and Risk of Death in Europe. <em>New England Journal of Medicine</em> <strong>359</strong>, 2105–2120 (2008).</p>
</div>
<div id="ref-Pasco2012">
<p>10. Pasco, J. A., Nicholson, G. C., Brennan, S. L. &amp; Kotowicz, M. A. Prevalence of obesity and the relationship between the body mass index and body fat: Cross-sectional, population-based data. <em>PLoS ONE</em> <strong>7</strong>, (2012).</p>
</div>
<div id="ref-Sahakyan2015">
<p>11. Sahakyan, K. R. <em>et al.</em> Normal-Weight Central Obesity: Implications for Total and Cardiovascular Mortality. <em>Annals of internal medicine</em> <strong>163</strong>, 827–835 (2015).</p>
</div>
<div id="ref-Hamer2017">
<p>12. Hamer, M., O’Donovan, G., Stensel, D. &amp; Stamatakis, E. Normal-Weight Central Obesity and Risk for Mortality. <em>Annals of Internal Medicine</em> <strong>166</strong>, 917–918 (2017).</p>
</div>
<div id="ref-WorldHealthOrganisation2008">
<p>13. World Health Organisation. <em>Waist Circumference and Waist-Hip Ratio: Report of a WHO Expert Consultation</em>. (WHO, 2008).</p>
</div>
<div id="ref-Collaboration2009">
<p>14. Prospective Studies Collaboration <em>et al.</em> Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. <em>Lancet (London, England)</em> <strong>373</strong>, 1083–1096 (2009).</p>
</div>
<div id="ref-Lehr2012">
<p>15. Lehr, S., Hartwig, S. &amp; Sell, H. Adipokines: A treasure trove for the discovery of biomarkers for metabolic disorders. <em>PROTEOMICS – Clinical Applications</em> <strong>6</strong>, 91–101 (2012).</p>
</div>
<div id="ref-Fasshauer2015">
<p>16. Fasshauer, M. &amp; Blüher, M. Adipokines in health and disease. <em>Trends in Pharmacological Sciences</em> <strong>36</strong>, 461–470 (2015).</p>
</div>
<div id="ref-Luo2016">
<p>19. Luo, L. &amp; Liu, M. Adipose tissue in control of metabolism. <em>Journal of Endocrinology</em> <strong>231</strong>, R77–R99 (2016).</p>
</div>
<div id="ref-Shin2014">
<p>20. Shin, S.-Y. <em>et al.</em> An atlas of genetic influences on human blood metabolites. <em>Nature Genetics</em> <strong>46</strong>, 543 (2014).</p>
</div>
<div id="ref-Kettunen2016">
<p>21. Kettunen, J. <em>et al.</em> Genome-wide study for circulating metabolites identifies 62 loci and reveals novel systemic effects of LPA. <em>Nature Communications</em> <strong>7</strong>, 11122 (2016).</p>
</div>
<div id="ref-Wacholder1998">
<p>22. Wacholder, S. <em>et al.</em> The kin-cohort study for estimating penetrance. <em>American journal of epidemiology</em> <strong>148</strong>, 623–630 (1998).</p>
</div>
<div id="ref-Joshi2017">
<p>24. Joshi, P. K. <em>et al.</em> Genome-wide meta-analysis associates HLA-DQA1/DRB1 and LPA and lifestyle factors with human longevity. <em>Nature communications</em> <strong>8</strong>, 910 (2017).</p>
</div>
</div>
            </section>

          </div>
        </div>
      </div>
<a href="star-report.html" class="navigation navigation-prev navigation-unique" aria-label="Previous page"><i class="fa fa-angle-left"></i></a>

    </div>
  </div>
<script src="libs/gitbook-2.6.7/js/app.min.js"></script>
<script src="libs/gitbook-2.6.7/js/lunr.js"></script>
<script src="libs/gitbook-2.6.7/js/clipboard.min.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-search.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-sharing.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-fontsettings.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-bookdown.js"></script>
<script src="libs/gitbook-2.6.7/js/jquery.highlight.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-clipboard.js"></script>
<script>
gitbook.require(["gitbook"], function(gitbook) {
gitbook.start({
"sharing": {
"github": false,
"facebook": true,
"twitter": true,
"linkedin": false,
"weibo": false,
"instapaper": false,
"vk": false,
"all": ["facebook", "twitter", "linkedin", "weibo", "instapaper"]
},
"fontsettings": {
"theme": "white",
"family": "sans",
"size": 2
},
"edit": {
"link": null,
"text": null
},
"history": {
"link": null,
"text": null
},
"view": {
"link": null,
"text": null
},
"download": null,
"toc": {
"collapse": "none"
},
"search": false
});
});
</script>

</body>

</html>
